AI-based tool set to improve pancreatic cancer treatment
A new artificial-intelligence-based tool has been developed to predict genomic subtypes of pancreatic cancer
2 minute read
A new artificial-intelligence-based tool has been developed to predict genomic subtypes of pancreatic cancer
Guerbet’s Chief Digital Officer, François Nicolas, on steering a 95 year old company from manufacturing radiology agents to developing AI solutions
French MedTech company Carmat receives approval to market its Total Artificial Heart in the EU as a bridge to a transplant